T3+T4 [30+120mcg] Genesis

£80.00

T3+T4 [30+120mcg] Genesis combines triiodothyronine and thyroxine hormones for metabolic research. Genesis-manufactured thyroid hormone combination for in-vitro laboratory studies examining metabolic pathways and cellular energy processes.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
T3+T4 [30+120mcg] Genesis
T3+T4 [30+120mcg] Genesis
£80.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

T3+T4 [30+: Compound Profile

T3+T4 [30+120mcg] Genesis is a synthetic thyroid hormone combination comprising 30mcg triiodothyronine (T3) and 120mcg thyroxine (T4) per tablet. This pharmaceutical-grade research compound enables laboratory investigations into thyroid hormone signalling pathways, metabolic regulation mechanisms, and cellular energy homeostasis. Genesis manufactures this dual-hormone formulation to support comprehensive endocrine research protocols examining the synergistic effects of T3 and T4 on metabolic processes. Researchers at Stroid UK Shop utilise this compound alongside other fat burning research chemicals to investigate metabolic modulatory pathways in controlled laboratory environments.

Laboratory Applications

Scientific studies examine T3+T4 combinations for their effects on basal metabolic rate regulation, mitochondrial biogenesis, and thermogenic protein expression. Research protocols investigate how this dual-hormone approach influences lipolysis pathways, glucose metabolism, and cellular oxygen consumption rates. Laboratory analyses focus on the temporal dynamics of T3 versus T4 activity, examining conversion ratios and receptor binding affinities across different tissue models. Comparative studies evaluate this formulation against individual hormone preparations to understand synergistic metabolic effects. Research teams studying metabolic disorders examine how controlled T3+T4 administration affects cellular energy production and substrate utilisation patterns. These investigations complement broader endocrine research programmes examining selective androgen receptor modulators and metabolic peptides in cellular energy regulation studies.

Technical Specifications

T3+T4 Genesis Research Compound Specifications
Parameter Value
T3 Content 30mcg per tablet
T4 Content 120mcg per tablet
Manufacturer Genesis Pharmaceuticals
Form Oral tablets
Purity Verify with supplier
Storage Room temperature, dry conditions

Research Compliance

T3+T4 [30+120mcg] Genesis is manufactured exclusively for in-vitro research applications and laboratory studies. This product is not intended for human consumption, therapeutic use, or any application outside controlled scientific research environments. Researchers must ensure proper laboratory protocols and safety procedures when handling thyroid hormone compounds for experimental purposes.

Related